Literature DB >> 12948096

First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination.

Tsung-Hsuan Lai1, Su-Chee Chen, Ming-Song Tsai, Fa-Kung Lee, Chi-Feng Wei.   

Abstract

PURPOSE: To evaluate whether achieving a singleton pregnancy by IUI affects the results of first-trimester screening for Down syndrome compared to naturally conceived pregnancy.
METHODS: Forty-nine IUI and 3059 naturally conceived singleton pregnancies were included in the study. Ovulation in IUI pregnancies was induced by clomiphene and human menopausal gonadotropin. Progesterone was given after insemination for 2 weeks. Down syndrome screening was performed using a combination of maternal age, fetal nuchal translucency, and maternal serum concentrations of free beta-hCG and PAPP-A during the period of 10-14 weeks' gestation.
RESULTS: In IUI pregnancies, nuchal translucency thickness and the levels of PAPP-A were significantly higher. The values of free beta-hCG were not statistically different between the two groups. The screen-positive rate in IUI pregnancies was significantly higher (14.3% vs. 7.1%).
CONCLUSIONS: Singleton pregnancies achieved by IUI have a higher screen-positive rate. Not only elder maternal age but also exogenous hormones given during the process of ovulation induction and after conception may play an important factor influencing positive screening results.

Entities:  

Mesh:

Year:  2003        PMID: 12948096      PMCID: PMC3455274          DOI: 10.1023/a:1024813708875

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  17 in total

1.  One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester.

Authors:  K Spencer; C E Spencer; M Power; A Moakes; K H Nicolaides
Journal:  BJOG       Date:  2000-10       Impact factor: 6.531

2.  Maternal serum screening for down syndrome in pregnancies conceived by intra-uterine insemination.

Authors:  T Y Hsu; C Y Ou; J J Hsu; F T Kung; S Y Chang; Y K Soong
Journal:  Prenat Diagn       Date:  1999-11       Impact factor: 3.050

Review 3.  Antenatal screening for Down's syndrome in assisted reproductive pregnancies.

Authors:  R Maymon; E Dreazen; Z Weinraub; I Bukovsky; A Herman
Journal:  Hum Reprod Update       Date:  1999 Sep-Oct       Impact factor: 15.610

4.  Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.

Authors:  K H Nicolaides; M L Brizot; R J Snijders
Journal:  Br J Obstet Gynaecol       Date:  1994-09

5.  First trimester screening for Down syndrome and assisted reproduction: no basis for concern.

Authors:  K R Wøjdemann; S O Larsen; A Shalmi; K Sundberg; M Christiansen; A Tabor
Journal:  Prenat Diagn       Date:  2001-07       Impact factor: 3.050

6.  A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.

Authors:  K Spencer; V Souter; N Tul; R Snijders; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  1999-04       Impact factor: 7.299

7.  First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction.

Authors:  A W Liao; V Heath; N Kametas; K Spencer; K H Nicolaides
Journal:  Hum Reprod       Date:  2001-07       Impact factor: 6.918

8.  Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.

Authors:  N J Wald; N White; J K Morris; W J Huttly; J A Canick
Journal:  Br J Obstet Gynaecol       Date:  1999-12

9.  Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.

Authors:  K Spencer; A W Liao; H Skentou; S Cicero; K H Nicolaides
Journal:  Prenat Diagn       Date:  2000-06       Impact factor: 3.050

10.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

Authors:  K H Nicolaides; G Azar; D Byrne; C Mansur; K Marks
Journal:  BMJ       Date:  1992-04-04
View more
  5 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 4.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 5.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.